Climate Change Data

Environmental Metrics

ESG Focus Areas

• Environmental

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Not disclosed

Climate Goals & Targets

Environmental Challenges

• Not disclosed

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Not disclosed

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Nomination of Sylvie Guinard as an independent director and Philippe Dujardin as a director.
• Ratification of Pascal Reber's appointment as auditor.

Climate Goals & Targets

Environmental Challenges

• Potential impacts from the war in Ukraine on the company's activities, though not quantifiable at the time of the report.
• Uncertainty regarding the evolution of the health crisis and its potential impact on product testing and regulatory processes.

Mitigation Strategies

• Not disclosed

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: IFRS

Certifications: Null

Third-party Assurance: Mazars

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Biocontrol product for plant protection
• Biocide product for water treatment

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Not disclosed

Environmental Achievements

• Not disclosed

Social Achievements

• Not disclosed

Governance Achievements

• Significant change in leadership to better align with the new strategic plan. New board brings significant experience of transitioning from start-up to commercial operations as well as industry expertise in the biocontrol, health and cosmetics industries.

Climate Goals & Targets

Environmental Challenges

• Adverse weather conditions in 2023 delayed field trials, pushing back product approval timelines.
• Scaling up production.
• Rising energy costs.
• Product market acceptance.
• Potential IP theft.
• Securing finance for capacity expansion and ongoing operations.

Mitigation Strategies

• Postponed plans to build a large industrial-scale production plant in favor of a more moderate expansion at its headquarters, aligning investment costs with expected sales revenues, focusing on high-margin products, reducing capex demands, and increasing flexibility to outsource production.
• Developing a recirculation system to address water scarcity.
• Seeking distribution partners for biocontrol and cosmetics products.
• Global patent protection for the use of W. magna amoeba lysate as a biofungicide until 2037.
• Seeking to raise €5–10m in additional funding.

Supply Chain Management

Supplier Audits: Not disclosed

Responsible Procurement

• Not disclosed

Climate-Related Risks & Opportunities

Physical Risks

• Not disclosed

Transition Risks

• Not disclosed

Opportunities

• Not disclosed

Reporting Standards

Frameworks Used: Null

Certifications: Null

Third-party Assurance: Not disclosed

UN Sustainable Development Goals

• Not disclosed

Not disclosed

Sustainable Products & Innovation

• Axpera biocontrol solution
• Amoeba active ingredient in skincare cosmetics

Awards & Recognition

• Not disclosed

Environmental Metrics

ESG Focus Areas

• Sustainability
• Bio-based solutions

Environmental Achievements

• Development of natural microbiological solutions based on amoebas, replacing chemical products.
• Zero toxicity to humans and ecotoxicity demonstrated by numerous tests and studies.

Social Achievements

• Realigned team committed to the success of Amoéba’s new strategy.
• Collaboration with various partners (Labskin Creations, PKDerm, BioTK, IEC) for research and clinical trials.

Governance Achievements

• New dynamic driven by a united team with solid experience in the health sector.
• Proposed legal reorganization with operating companies for each business line (Q4 2024).

Climate Goals & Targets

Environmental Challenges

• Securing commercial partnerships for cosmetics and biocontrol products.
• Raising sufficient capital for operations and capacity investments.
• Navigating regulatory approvals for biocontrol products (Axpera).

Mitigation Strategies

• Prioritizing commercial partnerships with major consumer brands for cosmetics.
• Seeking financial partners for biocontrol and cosmetics sales subsidiaries.
• Outsourcing production capacity before potentially building a plant for biocontrol.
• Minimizing working capital requirements for sales startup.

Supply Chain Management

Climate-Related Risks & Opportunities

UN Sustainable Development Goals

• SDG 2 (Zero Hunger)
• SDG 3 (Good Health and Well-being)
• SDG 6 (Clean Water and Sanitation)
• SDG 9 (Industry, Innovation and Infrastructure)
• SDG 12 (Responsible Consumption and Production)
• SDG 13 (Climate Action)

Amoeba's products contribute to sustainable agriculture, reducing pesticide use and promoting healthier alternatives.

Sustainable Products & Innovation

• Axpera (biocontrol)
• Amoeba-based cosmetic ingredient

Awards & Recognition

• Innovation Award at the Plant BioProTech Congress in Reims (June 2022)